Biliary complications after adult-to-adult living-donor liver transplantation: An international multicenter study of 3633 cases.

bile leak biliary anastomotic stricture biliary complications liver transplantation living-donor liver transplantation

Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
28 Feb 2024
Historique:
received: 04 09 2023
revised: 22 02 2024
accepted: 22 02 2024
medline: 2 3 2024
pubmed: 2 3 2024
entrez: 1 3 2024
Statut: aheadofprint

Résumé

In living-donor liver transplantation, biliary complications including bile leaks and biliary anastomotic strictures remain significant challenges, with incidences varying across different centers. This multicentric retrospective study (2016-2020) included 3633 adult patients from 18 centers and aimed to identify risk factors for these biliary complications and their impact on patient survival. Incidences of bile leaks and biliary strictures were 11.4% and 20.6%, respectively. Key risk factors for bile leaks included multiple bile duct anastomoses (Odds Ratio [OR] 1.8), Roux-en-hepaticojejunostomy (OR 1.4), and a history of major abdominal surgery (OR 1.4). For biliary anastomotic strictures, risk factors were ABO-incompatibility (OR 1.4), blood loss >1 liter (OR 1.4), and previous abdominal surgery (OR 1.7). Patients experiencing biliary complications had extended hospital stays, increased incidence of major complications, and higher Comprehensive Complication Index (CCI®) scores. The impact on graft survival became evident after accounting for immortal time bias using time-dependent covariate survival analysis. Bile leaks and biliary anastomotic strictures were associated with adjusted hazard ratios of 1.7 and 1.8 for graft survival, respectively. The study underscores the importance of minimizing these risks through careful donor selection and preoperative planning, as biliary complications significantly affect graft survival despite available effective treatments.

Identifiants

pubmed: 38428639
pii: S1600-6135(24)00165-5
doi: 10.1016/j.ajt.2024.02.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.

Auteurs

Zhihao Li (Z)

Department of Surgery and Transplantation, Swiss HPB Center, University Hospital Zurich, Switzerland.

Ashwin Rammohan (A)

The Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Chennai, India.

Vasanthakumar Gunasekaran (V)

The Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Chennai, India.

Suyoung Hong (S)

Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea.

Itsuko Chih-Yi Chen (I)

Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Jongman Kim (J)

Department of Surgery, Samsung Medical Center, Seoul, South Korea.

Kris Ann Hervera Marquez (KA)

Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Shih Chao Hsu (SC)

Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.

Elvan Onur Kirimker (EO)

Department of Surgery, Ankara University School of Medicine, Ankara, Turkey.

Nobuhisa Akamatsu (N)

Artificial Organ and Transplantation Division and Hepato-Biliary-Pancreatic Surgery, University of Tokyo, Tokyo, Japan.

Oren Shaked (O)

Division of Transplantation, University of Pennsylvania, Philadelphia, PA.

Michele Finotti (M)

Division of Abdominal Transplantation, Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX.

Marcus Yeow (M)

Division of Hepatobiliary, Pancreatic Surgery and Liver Transplantation, University Surgical Cluster, National University Health System, Singapore.

Lara Genedy (L)

Eberhard Karls University of Tübingen, Department of General Visceral and Transplant Surgery, Tübingen, Germany.

Philipp Dutkowski (P)

Department of Surgery and Transplantation, Swiss HPB Center, University Hospital Zurich, Switzerland.

Silv O Nadalin (SO)

Eberhard Karls University of Tübingen, Department of General Visceral and Transplant Surgery, Tübingen, Germany.

Markus U Boehnert (MU)

Department of Surgery, Division of HPB & Transplant Surgery, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Wojciech G Polak (WG)

Department of Surgery, Division of HPB & Transplant Surgery, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Glenn K Bonney (GK)

Division of Hepatobiliary, Pancreatic Surgery and Liver Transplantation, University Surgical Cluster, National University Health System, Singapore.

Abhishek Mathur (A)

Liver and Abdominal Transplant Surgery, Columbia University Irving Medical Center, New York, NY.

Benjamin Samstein (B)

Liver and Abdominal Transplant Surgery, Columbia University Irving Medical Center, New York, NY.

Jean C Emond (JC)

Liver and Abdominal Transplant Surgery, Columbia University Irving Medical Center, New York, NY.

Giuliano Testa (G)

Division of Abdominal Transplantation, Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX.

Kim M Olthoff (KM)

Division of Transplantation, University of Pennsylvania, Philadelphia, PA.

Charles B Rosen (CB)

Department of Surgery, Division of Transplantation Surgery, Mayo Clinic, Rochester, MN.

Julie K Heimbach (JK)

Department of Surgery, Division of Transplantation Surgery, Mayo Clinic, Rochester, MN.

Timucin Taner (T)

Department of Surgery, Division of Transplantation Surgery, Mayo Clinic, Rochester, MN.

Tiffany Cl Wong (TC)

Department of Surgery, The University of Hong Kong, Hong Kong, People's Republic of China.

Chung-Mau Lo (CM)

Department of Surgery, The University of Hong Kong, Hong Kong, People's Republic of China.

Kiyoshi Hasegawa (K)

Artificial Organ and Transplantation Division and Hepato-Biliary-Pancreatic Surgery, University of Tokyo, Tokyo, Japan.

Deniz Balci (D)

Department of Surgery, Ankara University School of Medicine, Ankara, Turkey.

Mark Cattral (M)

Multi-Organ Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.

Gonzalo Sapisochin (G)

Multi-Organ Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.

Nazia Selzner (N)

Multi-Organ Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.

Long Bin Jeng (LB)

Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.

Dieter Broering (D)

Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Jae-Won Joh (JW)

Department of Surgery, Samsung Medical Center, Seoul, South Korea.

Chao-Long Chen (CL)

Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Kyung-Suk Suh (KS)

Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea.

Mohamed Rela (M)

The Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Chennai, India.

Pierre-Alain Clavien (PA)

Department of Surgery and Transplantation, Swiss HPB Center, University Hospital Zurich, Switzerland. Electronic address: clavien@access.uzh.ch.

Classifications MeSH